150 related articles for article (PubMed ID: 38679983)
41. Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen-detected cervical precancer.
Inturrisi F; Lissenberg-Witte BI; Veldhuijzen NJ; Bogaards JA; Ronco G; Meijer CJLM; Berkhof J
Int J Cancer; 2021 Jan; 148(2):320-328. PubMed ID: 32663316
[TBL] [Abstract][Full Text] [Related]
42. Human papillomavirus infection in women with and without cervical cancer in Tbilisi, Georgia.
Alibegashvili T; Clifford GM; Vaccarella S; Baidoshvili A; Gogiashvili L; Tsagareli Z; Kureli I; Snijders PJ; Heideman DA; van Kemenade FJ; Meijer CJ; Kordzaia D; Franceschi S
Cancer Epidemiol; 2011 Oct; 35(5):465-70. PubMed ID: 21292583
[TBL] [Abstract][Full Text] [Related]
43. Prevalence and carcinogenic risk of high-risk human papillomavirus subtypes in different cervical cytology: a study of 124,251 cases from the largest academic center in China.
Tao X; Zhang H; Wang S; Chen T; Cong Q; Wang L; Zhou X; Zhao C
J Am Soc Cytopathol; 2021; 10(4):391-398. PubMed ID: 33906830
[TBL] [Abstract][Full Text] [Related]
44. Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in Guatemala.
Lou H; Gharzouzi E; Guerra SP; Fokom Domgue J; Sawitzke J; Villagran G; Garland L; Boland JF; Wagner S; Rosas H; Troxler J; McMillen H; Kessing B; Alvirez E; Castillo M; Morales H; Argueta V; Rosingh A; van Aerde-van Nunen FJHB; Lopez G; Pinedo HM; Schiffman M; Dean M; Orozco R
BMC Cancer; 2018 May; 18(1):562. PubMed ID: 29764400
[TBL] [Abstract][Full Text] [Related]
45. Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study).
Orlando G; Tanzi E; Chatenoud L; Gramegna M; Rizzardini G;
BMC Cancer; 2012 May; 12():204. PubMed ID: 22646512
[TBL] [Abstract][Full Text] [Related]
46. Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants.
Wang SS; Zuna RE; Wentzensen N; Dunn ST; Sherman ME; Gold MA; Schiffman M; Wacholder S; Allen RA; Block I; Downing K; Jeronimo J; Carreon JD; Safaeian M; Brown D; Walker JL
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):113-20. PubMed ID: 19124488
[TBL] [Abstract][Full Text] [Related]
47. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
[No Abstract] [Full Text] [Related]
48. Human Papillomavirus Genotyping among Different Cervical Smears in Duhok/Iraq.
Pity IS; Abdo HM; Goreal AA
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2059-2064. PubMed ID: 31350966
[TBL] [Abstract][Full Text] [Related]
49. Prevalence of high-risk human papillomavirus infection and cytologic results in Thailand.
Swangvaree SS; Kongkaew P; Rugsuj P; Saruk O
Asian Pac J Cancer Prev; 2010; 11(6):1465-8. PubMed ID: 21338181
[TBL] [Abstract][Full Text] [Related]
50. Clinical Evaluation of DNA Ploidy for the Triage of HPV-Positive Chinese Women During Cervical Cancer Screening.
Cang W; Li Q; Gu L; Hong Z; Hu Y; Di W; Qiu L
Cancer Prev Res (Phila); 2021 Mar; 14(3):355-362. PubMed ID: 33229338
[TBL] [Abstract][Full Text] [Related]
51. The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China.
Zhang J; Zhang D; Yang Z; Wang X; Wang D
BMC Cancer; 2020 May; 20(1):443. PubMed ID: 32429919
[TBL] [Abstract][Full Text] [Related]
52. Human papillomavirus prevalence and type-distribution among women in Zhejiang Province, Southeast China: a cross-sectional study.
Liu XX; Fan XL; Yu YP; Ji L; Yan J; Sun AH
BMC Infect Dis; 2014 Dec; 14():708. PubMed ID: 25523884
[TBL] [Abstract][Full Text] [Related]
53. Genotype distribution of human papillomavirus in women with abnormal cervical cytology in an esophageal carcinoma high incidence area of China.
Mai RQ; Huang B; Shen L; Zhang GH; Hong LL; Cai YM
Asian Pac J Cancer Prev; 2014; 15(12):4945-50. PubMed ID: 24998569
[TBL] [Abstract][Full Text] [Related]
54. Pre-vaccination prevalence of high-risk human papillomaviruses (HPV) in women from Kosovo and their related sociodemographic characteristics.
Zejnullahu Raçi P; Hošnjak L; Poljak M; Lepej SŽ; Vince A
Ginekol Pol; 2018; 89(9):485-494. PubMed ID: 30318575
[TBL] [Abstract][Full Text] [Related]
55. Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer.
Song T; Seong SJ; Lee SK; Kim BR; Ju W; Kim KH; Nam K; Sim JC; Kim TJ
J Obstet Gynaecol; 2020 Feb; 40(2):240-246. PubMed ID: 31340702
[TBL] [Abstract][Full Text] [Related]
56. The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women.
Zhao X; Wu Q; Wang X; Fu Y; Zhang X; Tian X; Cheng B; Lu B; Yu X; Lan S; Lu W; Ma D; Cheng X; Xie X
Clin Microbiol Infect; 2018 Dec; 24(12):1322-1327. PubMed ID: 29518562
[TBL] [Abstract][Full Text] [Related]
57. Comparative Assessment of a Self-sampling Device and Gynecologist Sampling for Cytology and HPV DNA Detection in a Rural and Low Resource Setting: Malaysian Experience.
Latiff LA; Ibrahim Z; Pei CP; Rahman SA; Akhtari-Zavare M
Asian Pac J Cancer Prev; 2015; 16(18):8495-501. PubMed ID: 26745108
[TBL] [Abstract][Full Text] [Related]
58. Respective prevalence of high-risk HPVgenotypes in cervical neoplasia in Senegal.
Diop-Ndiaye H; Sastre-Garau X; Drame A; Dembele B; Ba NN; Diop-Diongue O; Mbow M; Diakhaby MEB; Woto-Gaye G; Toure Kane C; Diop M
J Med Virol; 2021 Aug; 93(8):5110-5117. PubMed ID: 33851737
[TBL] [Abstract][Full Text] [Related]
59. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.
Denny L; Adewole I; Anorlu R; Dreyer G; Moodley M; Smith T; Snyman L; Wiredu E; Molijn A; Quint W; Ramakrishnan G; Schmidt J
Int J Cancer; 2014 Mar; 134(6):1389-98. PubMed ID: 23929250
[TBL] [Abstract][Full Text] [Related]
60. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]